Skip links
Companies
› United States › NUVECTIS PHARMA, INC.

NUVECTIS PHARMA, INC.

Active

Registration No.
0101061365
Incorporation Date
2022-07-19
Company Type
Not disclosed
Address
FORT LEE, United States
Website
www.nuvectis.com/
Source: New Jersey Division of Revenue & Enterprise Services

NUVECTIS PHARMA, INC. is a registered legal entity registered in United States under 0101061365, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 19 July 2022 and lists its registered address as FORT LEE, United States. 2 shareholders are on record for NUVECTIS PHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 22 October 2026.

Data Provenance
This record is sourced directly from official government registries, including New Jersey Division of Revenue & Enterprise Services.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Two shareholders are currently on record for NUVECTIS PHARMA, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 17.2% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 2.7%.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Vanguard Group Inc 17.2% New Jersey Division of Revenue & Enterprise Services
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund 2.7% New Jersey Division of Revenue & Enterprise Services

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Co-founder, Chairman, Ceo & President of NUVECTIS PHARMA, INC. currently on record is Ron Bentsur M.b.a.; five officers are currently on record for NUVECTIS PHARMA, INC., filed with New Jersey Division of Revenue & Enterprise Services.

Management authority at NUVECTIS PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

RB
Ron Bentsur M.b.a. ACTIVE

Residence
🇺🇸 United States
Occupation
Co-founder, Chairman, Ceo & President

EP
Enrique Poradosu Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Co-founder, Executive Vp, Chief Scientific & Business Officer

SS
Shay Shemesh ACTIVE

Residence
🇺🇸 United States
Occupation
Co-founder, Executive Vp, Chief Development & Operations Officer

MC
Michael Carson Cpa ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Finance

MC
Michael Carson C.p.a. ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Finance

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Need the full UBO picture on NUVECTIS PHARMA, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns NUVECTIS PHARMA, INC.?

Two shareholders are currently on record for NUVECTIS PHARMA, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 17.2% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 2.7%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is NUVECTIS PHARMA, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for NUVECTIS PHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does NUVECTIS PHARMA, INC. have on record?

2 shareholders are shown on record for NUVECTIS PHARMA, INC..

What is NUVECTIS PHARMA, INC.'s company registration number?

NUVECTIS PHARMA, INC.'s registration number is 0101061365, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.

Is NUVECTIS PHARMA, INC. still an active company?

NUVECTIS PHARMA, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.

When was NUVECTIS PHARMA, INC. incorporated?

NUVECTIS PHARMA, INC. was incorporated on 19 July 2022, according to New Jersey Division of Revenue & Enterprise Services.

What is NUVECTIS PHARMA, INC.'s registered address?

The registered address on file for NUVECTIS PHARMA, INC. is FORT LEE, United States.

Who are the officers/directors of NUVECTIS PHARMA, INC.?

The Co-founder, Chairman, Ceo & President of NUVECTIS PHARMA, INC. currently on record is Ron Bentsur M.b.a.; five officers are currently on record for NUVECTIS PHARMA, INC., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at NUVECTIS PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Can Zavia monitor changes to NUVECTIS PHARMA, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to NUVECTIS PHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access NUVECTIS PHARMA, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like NUVECTIS PHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 22 October 2026.

This website uses cookies to improve your web experience.